Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current assets
Cash	$ 125	$ 1,331
Receivable-related party	34,582	15,000
Total current assets	34,707	16,331
Property and equipment
Office and laboratory equipment and leasehold improvements	784,330	784,330
Less: Accumulated depreciation	(774,982)	(771,568)
Total property and equipment, net	9,348	12,762
Other assets	7,000	7,000
TOTAL ASSETS	51,055	36,093
Current liabilities
Accounts payable	1,214,127	1,191,148
Accounts payable-related party	356,611	314,652
Accrued expenses	2,357,572	2,261,572
Notes payable	10,800	10,800
Convertible notes payable	915,162	895,162
Loan from shareholder	645,271	645,271
Total Current liabilities	5,499,543	5,318,605
Stockholders' deficit:
Series A preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 4,600 shares issued and outstanding as of March 31, 2013 and December 31, 2012, respectively; Series B preferred stock, par value $0.001 per share, 30,000,000 shares authorized, 19,760,000 shares issued and outstanding as of March 31, 2013 and December 31, 2012, respectively	15,415	15,415
Common stock, par value $0.001 per share, 300,000,000 shares authorized, 31,481,590 and 31,481,590 shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively	31,481	31,481
Additional paid-in capital	18,073,871	18,073,871
Deficit accumulated during the development stage	(23,569,255)	(23,403,279)
Total stockholders' deficit of Genethera, Inc.	(5,448,488)	(5,282,512)
Non-controlling interest	0	0
Total stockholders deficit	(5,448,488)	(5,282,512)
TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT	51,055	36,093
Series A preferred stock
Stockholders' deficit:
Series A preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 4,600 shares issued and outstanding as of March 31, 2013 and December 31, 2012, respectively; Series B preferred stock, par value $0.001 per share, 30,000,000 shares authorized, 19,760,000 shares issued and outstanding as of March 31, 2013 and December 31, 2012, respectively	5	5
Series B preferred stock
Stockholders' deficit:
Series A preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 4,600 shares issued and outstanding as of March 31, 2013 and December 31, 2012, respectively; Series B preferred stock, par value $0.001 per share, 30,000,000 shares authorized, 19,760,000 shares issued and outstanding as of March 31, 2013 and December 31, 2012, respectively	$ 15,410	$ 15,410